St. Louis, MO (PRWEB) June 16, 2015
Attorneys handling national Xarelto lawsuits report that the number of cases consolidated as part of MDL 2592 now exceeds 550, according to court documents.* Each of the claims shares common questions of fact and have been transferred to the Eastern District of Louisiana for consolidated pretrial proceedings. Last month, the Judicial Panel on Multidistrict Litigation reported a total of 434 cases included in the litigation; as of June 15, 2015, the number of national Xarelto lawsuits has risen to 552, according to official court documents.
“As pretrial proceedings move forward, new cases are being added for inclusion in the MDL. The purpose of multidistrict litigation is to avoid duplicative discovery in order to promote efficiency and consistency in the court’s handling of these Xarelto cases. As more Americans learn about the existence of Xarelto lawsuits making allegations of internal bleeding injuries and wrongful death, we expect the number of cases to continue to rise,” explained Jim Onder of the Onder Law Firm.
Each of the 552 claims now pending in U.S. District Court in the Eastern District of Louisiana has been approved for consolidation because it shares “common questions of fact”, according to court documents. In other words, these cases all make the same allegations against the same defendant(s). In the case of Xarelto lawsuits, the plaintiffs include individuals and the family members of individuals who allegedly suffered severe internal bleeding while taking Xarelto, according to court documents. These plaintiffs allege the pharmaceutical company responsible for marketing Xarelto, Janssen Research & Development (a subsidiary of Johnson & Johnson) knew or should have known of the increased risk of serious internal bleeding caused by Xarelto and should have warned consumers, according to court documents. Furthermore, these Xarelto lawsuit claims allege plaintiffs were not warned of the lack of a known antidote to stop bleeding once it had started in a patient taking Xarelto, according to court documents.
These Xarelto attorneys provide regular news updates and no-cost Xarelto lawsuit case evaluation at XareltoContingencyLawsuit.com.
Xarelto lawsuits attempt to recover damages for individuals and families who have suffered or lost a loved one as a result of bleeding or another related medical condition they attribute to Xarelto. Attorneys handling Xarelto lawsuits throughout the United States are now accepting claims from persons and their loved ones who suffered from severe internal bleeding or hemorrhagic stroke while taking Xarelto. Lawyers are investigating these inquiries for possible Xarelto lawsuits. The Onder Law Firm is renowned for its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Individuals and the family members of individuals who have suffered from internal bleeding and have taken Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website.
The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firms Xarelto attorneys provide information to the public at http://www.XareltoContingencyLawsuit.com.
*Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592, United States District Court, Eastern District of Louisiana